A novel locus for canine osteosarcoma (OSA1) maps to CFA34, the canine orthologue of human 3q26

Jeffrey C Phillips1, Luis Lembcke, Tamara Chamberlin

  • 1College of Veterinary Medicine, Department of Small Animal Clinical Sciences, 2407 River Drive, C247 Veterinary Teaching Hospital, Knoxville, TN 37996-4544, USA. jphill35@utk.edu

Genomics
|July 22, 2010
PubMed

Insights

Researchers identified a specific gene linked to bone cancer in Scottish Deerhounds. This discovery offers new insights into osteosarcoma genetics in both dogs and humans, advancing cancer research.

Area of Science:

  • Comparative Oncology
  • Canine Genetics
  • Cancer Genomics

Background:

  • Spontaneous canine tumors closely mimic human cancers in clinical and molecular aspects.
  • Scottish Deerhounds, a giant breed, have a high incidence of bone cancer (osteosarcoma).
  • Previous studies suggested a major gene influences osteosarcoma in this breed.

Purpose of the Study:

  • To investigate the genetic basis of osteosarcoma in Scottish Deerhounds using a whole genome mapping approach.
  • To identify specific genetic loci linked to the osteosarcoma phenotype in a large pedigree.

Main Methods:

  • Utilized a whole genome mapping strategy.
  • Analyzed a four-generation pedigree of Scottish Deerhounds exhibiting osteosarcoma.
  • Evaluated linkage between the osteosarcoma phenotype and genetic markers.

Main Results:

  • Found significant evidence of linkage (Zmax=5.766) between osteosarcoma and markers on Canine Chromosome 34 (CFA34).
  • This region on CFA34 is syntenic to human chromosome 3q26.
  • Identified a novel locus associated with osteosarcoma susceptibility.

Conclusions:

  • A specific genetic locus on CFA34 is strongly associated with osteosarcoma in Scottish Deerhounds.
  • This finding provides critical insights into the genetic underpinnings of osteosarcoma in canines.
  • The identified locus may also inform our understanding of human osteosarcoma genetics due to conserved synteny.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...